Integer Holdings Co. (NYSE:ITGR) Stock Position Lowered by PNC Financial Services Group Inc.

PNC Financial Services Group Inc. lowered its position in shares of Integer Holdings Co. (NYSE:ITGR) by 32.1% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,243 shares of the medical equipment provider’s stock after selling 1,530 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Integer were worth $430,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the company. Mather Group LLC. increased its position in shares of Integer by 304.3% in the fourth quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 143 shares in the last quarter. R Squared Ltd acquired a new position in Integer in the 4th quarter worth approximately $44,000. Versant Capital Management Inc boosted its stake in Integer by 98.4% in the 4th quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock worth $49,000 after purchasing an additional 183 shares during the period. Principal Securities Inc. grew its position in Integer by 31.2% during the 4th quarter. Principal Securities Inc. now owns 639 shares of the medical equipment provider’s stock worth $85,000 after purchasing an additional 152 shares in the last quarter. Finally, Contravisory Investment Management Inc. raised its stake in Integer by 210.8% during the 4th quarter. Contravisory Investment Management Inc. now owns 693 shares of the medical equipment provider’s stock valued at $92,000 after purchasing an additional 470 shares during the period. 99.29% of the stock is owned by institutional investors and hedge funds.

Integer Stock Down 3.8 %

NYSE:ITGR opened at $116.12 on Friday. The stock’s fifty day simple moving average is $132.96 and its 200-day simple moving average is $132.42. The firm has a market capitalization of $3.90 billion, a P/E ratio of 34.56, a P/E/G ratio of 1.72 and a beta of 1.24. The company has a quick ratio of 2.09, a current ratio of 2.95 and a debt-to-equity ratio of 0.62. Integer Holdings Co. has a 12-month low of $107.11 and a 12-month high of $146.36.

Integer (NYSE:ITGR) last announced its quarterly earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.46 by ($0.03). The firm had revenue of $449.50 million during the quarter, compared to analyst estimates of $446.28 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. Equities research analysts expect that Integer Holdings Co. will post 6.01 earnings per share for the current year.

Analyst Ratings Changes

ITGR has been the topic of a number of research analyst reports. Oppenheimer downgraded shares of Integer from an “outperform” rating to a “market perform” rating in a research report on Friday, February 21st. Truist Financial boosted their price target on shares of Integer from $147.00 to $163.00 and gave the company a “buy” rating in a report on Wednesday, December 11th. Benchmark increased their price objective on Integer from $140.00 to $150.00 and gave the stock a “buy” rating in a report on Friday, February 21st. KeyCorp boosted their target price on Integer from $144.00 to $154.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Finally, Citigroup raised their price target on Integer from $130.00 to $145.00 and gave the stock a “neutral” rating in a research note on Wednesday, December 11th. Two analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $149.00.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.